Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection
Volume
62
Pagination
533 - 540
DOI
10.1016/j.jhep.2014.12.003
Journal
JOURNAL OF HEPATOLOGY
Issue
ISSN
0168-8278
Metadata
Show full item recordAuthors
Agarwal, K; Fung, SK; Nguyen, TT; Cheng, W; Sicard, E; Ryder, SD; Flaherty, JF; Lawson, E; Zhao, S; Subramanian, GMCollections
- Centre for Immunobiology [1029]